Abstract
We examine the role of different network capabilities of companies that influence the formation of r&d partnerships in pharmaceutical biotechnology. Strategic network capabilities, specifically centrality-based capabilities and the efficiency with which companies choose their partners, are found to facilitate the formation of new partnerships. Unlike general experience with partnering, these strategic network capabilities play a crucial role in enabling companies to continue to interact with other companies through partnerships in a complex network setting.
| Original language | English |
|---|---|
| Pages (from-to) | 39-53 |
| Journal | British Journal of Management |
| Volume | 17 |
| DOIs | |
| Publication status | Published - 1 Jan 2006 |
Fingerprint
Dive into the research topics of 'Inter-firm R&D networks: the importance of strategic network capabilities for high-tech partnership formation'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver